Oath Planning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
971
+6
+0.6% +$2.23K 0.28% 48
2026
Q1
$283K Buy
965
+5
+0.5% +$1.64K 0.25% 56
2025
Q4
$336K Buy
+960
New +$324K 0.33% 48

Other funds holding ELV

Oath Planning's ELV Position: Q2 2026 in Review

Oath Planning increased its Elevance Health (ELV) stake by 0.62% in Q2 2026, buying an estimated $2.23K and bringing the position to 971 shares worth $375K. The position accounts for 0.28% of the portfolio, ranked #48.

Oath Planning first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Oath Planning held 971 shares of Elevance Health worth $375K as of Q2 2026.
  • Oath Planning bought 6 Elevance Health shares in Q2 2026, an estimated $2.23K.
  • Elevance Health made up 0.28% of Oath Planning's portfolio in Q2 2026, its #48 holding.
  • Oath Planning first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Oath Planning's 13F filing for Q2 2026, filed 24 Jul 2026.